Literature DB >> 8849944

Patterns of spread of recurrent intraabdominal sarcoma.

T A Sugarbaker1, D Chang, P Koslowe, P H Sugarbaker.   

Abstract

A prominent site for recurrence of retroperitoneal and visceral sarcoma is the abdominal cavity. In an attempt to understand the causation of local and regional recurrence, 21 sarcoma patients who had previously undergone "complete" surgical removal of the primary tumor were prospectively studied. Data were obtained retrospectively from the first operation and prospectively from the reoperative procedure at the Washington Cancer Institute. At the primary and reoperative surgeries, 9 abdominopelvic regions and 21 sites were scored and then cataloged in a standardized fashion. Tumor locations and surgical resections were statistically analyzed in an attempt to establish patterns of recurrence within the abdomen and pelvis. There was a significant difference in sites of recurrence when sarcomas that involved the parietal structures were compared with those that involved small bowel. Peritoneal implants (nodular recurrences) were uniformly present in both groups. In contrast, resection site recurrences were very common with primary sarcomas invested by parietal peritoneum, while they were absent in those covered by visceral peritoneum. When primary surgeries were compared with reoperations, there was an increasing intraabdominal dissemination; the mean number of regions increased from 1.81 to 5.13. The change in distribution of sarcoma deposits at reoperation was greatest in right upper (because of liver surface) central and pelvic abdominopelvic regions and lowest in the left upper and epigastrium. The four anatomic sites that revealed a significant increase in involvement at the time of recurrence were the greater omentum, liver surface, large bowel, and the cul-de-sac of Douglas (all p < 0.002). Regions with tumor involvement or regions subjected to surgical trauma at the time of primary sarcoma resection were significantly more likely to show sarcoma deposits than to be sarcoma free at reoperation. These data taken together may suggest that sarcoma tumor emboli are frequently present in the abdomen at the time of resection of the primary cancer and that these tumor emboli are entrapped in fibrinous material at or immediately adjacent to sites of surgical trauma and along narrow margins of resection. Tumor cell entrapment of sarcoma emboli released into the peritoneal cavity prior to or at the time of sarcoma resection may help explain the distribution of nodular and fusiform recurrence of abdominopelvic sarcoma.

Entities:  

Mesh:

Year:  1996        PMID: 8849944     DOI: 10.1007/978-1-4613-1247-5_5

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN: 0927-3042


  9 in total

1.  Effect of hyperthermic intraperitoneal chemotherapy in combination with cytoreductive surgery on the prognosis of patients with colorectal cancer peritoneal metastasis: a systematic review and meta-analysis.

Authors:  Ji Li; An-Ran Wang; Xiao-Dong Chen; Yu-Xin Zhang; Hong Pan; Shi-Qiang Li
Journal:  World J Surg Oncol       Date:  2022-06-14       Impact factor: 3.253

Review 2.  [Oligometastases in gastric and esophageal cancer : Current clinical trials and surgical concepts].

Authors:  S Beckert; A Königsrainer
Journal:  Chirurg       Date:  2018-07       Impact factor: 0.955

3.  Surgical results of patients with peritoneal carcinomatosis treated with cytoreductive surgery using a new technique named aqua dissection.

Authors:  Y Yonemura; A Elnemr; Y Endou; H Ishibashi; A Mizumoto; M Miura; Yan Li
Journal:  Gastroenterol Res Pract       Date:  2012-05-15       Impact factor: 2.260

4.  Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival for patients with peritoneal carcinomatosis from colorectal cancer: a phase II study from a Chinese center.

Authors:  Chao-Qun Huang; Xiao-Jun Yang; Yang Yu; Hai-Tao Wu; Yang Liu; Yutaka Yonemura; Yan Li
Journal:  PLoS One       Date:  2014-09-26       Impact factor: 3.240

5.  Conversion Surgery for Patients with Advanced Gastric Cancer with Peritoneal Carcinomatosis.

Authors:  Ting-Ying Lee; Guo-Shiou Liao; Hsiu-Lung Fan; Chung-Bao Hsieh; Teng-Wei Chen; De-Chuan Chan
Journal:  J Oncol       Date:  2021-11-10       Impact factor: 4.375

6.  Recent progress in the management of retroperitoneal sarcoma.

Authors:  R Cheifetz; C N Catton; R Kandel; B O'Sullivan; J Couture; C J Swallow
Journal:  Sarcoma       Date:  2001

7.  Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from colorectal cancer: a case-control study from a Chinese center.

Authors:  Chao-Qun Huang; Jue-Ping Feng; Xiao-Jun Yang; Yan Li
Journal:  J Surg Oncol       Date:  2013-12-27       Impact factor: 3.454

8.  Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy for Management of Peritoneal Sarcomatosis: A Preliminary Single-Center Experience from Saudi Arabia.

Authors:  Ahmed Abu-Zaid; Ayman Azzam; Mohammed Abuzaid; Tusneem Elhassan; Naryman Albadawi; Lynn Alkhatib; Osama AlOmar; Abdullah Alsuhaibani; Tarek Amin; Ismail A Al-Badawi
Journal:  Gastroenterol Res Pract       Date:  2016-04-24       Impact factor: 2.260

Review 9.  Conversion surgery for gastric cancer patients: A review.

Authors:  Tommaso Zurleni; Elson Gjoni; Michele Altomare; Stefano Rausei
Journal:  World J Gastrointest Oncol       Date:  2018-11-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.